A phase 2 study of venetoclax in combination with isatuximab and dexamethasone for relapsed/refractory multiple myeloma patients with t(11;14)

A phase 2 study of venetoclax in combination with isatuximab and dexamethasone for relapsed/refractory multiple…

read more

A phase I trial of selinexor, ruxolitinib and methylprednisolone for patients with relapsed/refractory multiple myeloma

A phase I trial of selinexor, ruxolitinib and methylprednisolone for patients with relapsed/refractory multiple myeloma…

read more